Prism Medico And Pharmacy Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2025 ,inter alia, to consider and approve Dear Sir/Madam, With ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Prism Medico and Pharmacy Ltd has informed BSE that its Board of Directors will meet on Wednesday, 28th May 2025 at 3:00 PM at the registered office in Kala Amb, Himachal Pradesh. The main agenda is to consider and approve the audited standalone financial results for the quarter and full financial year ended 31st March 2025, along with the auditor's report, under Regulation 33 of SEBI LODR. The filing is a routine compliance disclosure made under Regulation 29(1) of SEBI LODR Regulations, 2015. Any other routine business matters may also be discussed. The intimation was signed by Director Davender Singh.
This is a standard pre-results intimation with no immediate price-moving action; shareholders should watch for the actual audited FY25 earnings numbers and any dividend or related announcements that may come out of the meeting on 28th May.